Nicholas Syn
@Nicholas_Syn
Followers
468
Following
86
Media
147
Statuses
1K
Dean's Fellow, Adj Asst Professor @NUS Medicine ML/AI in molecular & digital pathology Website: https://t.co/meoCH78ymP
National U of Singapore
Joined April 2018
Encouraged to be listed again among the Top 2% of Scientists ranking published by @Stanford and @ElsevierConnect for the 2nd year running, based on citations received during calendar year 2022😃 https://t.co/9Y8MTcPR3s
@NUSMedicine @NUSingapore @NUSResearch
1
0
17
Glad to have mentored @yaoneng_teo Phase V @NUSMedicine medical student in his undergraduate research opportunities programme project to clinch the only excellence award! Happy to see juniors have their work recognised. @yaohao_teo @Nicholas_Syn @Tonyli1992 @KianKPoh1 @chanyymark
0
2
9
Join us on January 19, 2024, 9 am EST, for the next @_ILTS_ Vanguard Webinar which will focus on liver tx pathology! This lecture is targeted to patient-fronting clinicians (hepatologists, transplant surgeons, and oncologists) Register here: https://t.co/CkmXvXuFBC
0
2
6
Another exciting ILTS Vanguard webinar!! To increase utilisation of marginal organs, we need help from pathologists. So let’s hear from the experts on “Liver Transplant Pathology-Snapshot of Cases” on Jan 19th 👍 @RyanChadha1 @Nicholas_Syn @_ILTS_
https://t.co/9OCX9StUW3
0
4
6
Always lovely to catch up with the first mentor who set me down this path, Prof Goh Boon Cher 😁 Wishing everyone a fantastic 2024! 😇
0
0
9
Join us on January 19, 2024, 9 am EST, for the next @_ILTS_ Vanguard Webinar which will focus on liver tx pathology! This lecture is targeted to patient-fronting clinicians (hepatologists, transplant surgeons, and oncologists) Register here: https://t.co/CkmXvXuFBC
0
2
6
#LiverTwitter #GITwitter Ep14 from @TheLiverFound marks an important episode that shares the effect of diet and nutrition in #NAFLD and the importance of #diet #intervention with Prof Manuel Romero Gomez! Listen free today! 🎧 https://t.co/D0hVp5w29L 📷 https://t.co/4eBVe58iir
0
2
6
#GITwitter #LiverTwitter 🔥 #Ultrasound and #MRI is used for screening #HCC... but how is the overall quality of both modality for #HCC screening🤔? @Nicholas_Syn @DrHuangDQ @DrLoomba @DrMarkMuthiah Free to read!: https://t.co/fkGxhNQ6vC !
0
7
18
Metrics are not the best reflection of scientific output.. but was encouraged to be recognised for the second year running on the World’s top 2% most cited researchers list which was initiated by Stanford University and published by Elsevier. https://t.co/UkDA67teKD
1
2
16
#LiverTwitter #GITwitter latest episode at the liver lounge shares a discussion on the latest @BritSocGastro guidelines in #cirrhosis! 🔥🔥 Listen free today! https://t.co/D0hVp5w29L
https://t.co/4eBVe58iir
0
6
17
https://t.co/yuIEhxMh8J
@_ILTS_ @ILTSJC @Rela_Institute @dbalci @kymwatt @TomoTanakaLTx @AShinginaMD @Nicholas_Syn @mikespiro All five consensus papers are published on SFSS in LDLT! @StanfordAbdTxp
0
15
41
#GITwitter #LiverTwitter Our team @TheLiverFound newly led global study on #NAFLD in #T2DM! The synergistic effect of NAFLD and DM 📈the risk of complications, so how many % of #DM have #NAFLD and #NASH? ❗️ ➡️ https://t.co/9GML9sD1nI
0
9
14
In a pooled analysis of 1,832,125 persons, the prevalence of NAFLD and NASH in T2D were 65% and 32%, respectively. 36% of individuals with T2D with NAFLD had clinically significant fibrosis (F2–F4), while 15% had advanced fibrosis (F3–F4). https://t.co/ewz4SrPj4L
@Gut_BMJ
0
4
9
🔥off the press @NatRevGastroHep
#HCC surveillance a/w ⬆️ survival ▶️Severely underutilized (<25% in cirrhosis) ▶️ NASH and alcohol 🚀+ a/w unique challenges ▶️ Mitigating strategies available ▶️ Novel biomarkers emerging @EASLedu @AASLDtweets
https://t.co/9t89zvAC6i
nature.com
Nature Reviews Gastroenterology & Hepatology - In this Review, Huang et al. discuss the current status of hepatocellular carcinoma surveillance, the remaining challenges, including the changing...
2
9
32
🆕Article in press @JHeptaology by @NUSingapore and @VCU_Liver researchers. Natural history of# NASH #cirrhosis in #livertransplant waitlist registrants Read it here👉 https://t.co/txoZO1X0cO
@WenHuiLim4 @VCUTransplant #LiverTwitter
0
6
14
#GITwitter #LiverTwitter🔥✅ Latest episode of our podcast from @TheLiverFound has been released! This week, we talk to @DrHuangDQ on the implications of #NAFLD/#MASLD on #HCC🔥Listen free now on your fav podcast application! https://t.co/D0hVp5w29L
0
4
18
#LiverTwitter #GITwitter 🔥🔥 happy to share the latest episode by @TheLiverFound with Prof Vincent Chen from Michigan on #MASH (#NASH) related Cirrhosis and it’s implications! Listen now at: 🎧 https://t.co/D0hVp5w29L 🎧 https://t.co/yvCHDwRUYd
0
6
10
#GITwitter #LiverTwitter 🔥Happy to share our study in @Gut_BMJ with prof @DrLoomba on the🌐 prevalence of #NAFLD in #T2DM. ➡️35.54% had F2-4, 14.95% had F3-4 within #NAFLD, and up to 23.62% with F3-4 in #NASH.❗️Important to reduce the global burden! https://t.co/sqCNgKh3qX
3
22
58
